Pfizer's Digital Innovation Center expands Start4Health27 program to Cyprus and Israel
The Pfizer Digital Innovation Center has announced the launch of the 5th cycle of its Start4Health27 program, which supports health-focused startups. For the first time since its inception, the program is expanding beyond Greece to include Cyprus and Israel, aiming to foster stronger connections between regional innovation ecosystems and facilitate the exchange of technological expertise.
Since its establishment in 2021, the initiative has hosted over 100 startups, with 24 receiving specialized support and some securing global collaborations with Pfizer. The 5th cycle targets companies at various development stages, focusing on sectors including digital health, computational biology, biomedical data, clinical trials, drug safety, and the empowerment of patients and medical professionals. Dr. Ioannis Pandis, head of Pfizer in Thessaloniki and the Digital Innovation Center, emphasized that this expansion leverages global Pfizer expertise to create high-impact healthcare solutions.
Interested companies may submit their applications for the program's two distinct tracks starting from November 18, 2026, with the deadline set for December 9, 2026.